Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

• PrefacePart A: Synthesis and characterization of silver nanoparticlesfor drug delivery1. History, introduction, and physicochemical properties of silver nanoparticles2. Synthesis methods and characterization parameters of silver nanoparticlesPart B: Application of silver nanoparticles in drug delivery3. Targeting strategies and clinical implications of bio-conjugated silver nanoparticles in drug delivery4. Silver nanoparticles for pharmaceutical and biomedical applications drug delivery5. Silver nanoparticles for cancer diagnosis and treatment of cancer6. Silver nanoparticles to enhance photodynamic action of photosensitizers7. Silver nanoparticles against multidrug-resistant bacteria and bacterial biofilm8. Silver nanoparticles in wound therapy and tissue regeneration9. Silver nanoparticles for drug delivery in inflammatory bowel disease10. Silver nanoparticles for the management of neurological diseases11. Nutritional plants, phytochemicals, microorganisms-derived silver nanoparticles and their diabetic managements12. Silver nanoparticles in dentistry13. Silver nanoparticles and their role in the treatment of endodontic infections14. Silver nanoparticles for treatment of COVID-19 and other viral diseasesPart C: Recent advances and regulatory aspects of silver nanoparticles15. Biological toxicity, safety issues, and environmental hazards associated with silver nanoparticles16. Silver nanoparticleinduced ecotoxicity17. Clinical translation of silver nanoparticles into the market18. Conclusion and future prospective of silver nanoparticles